PF

PFE PFIZER INC

2026Q2 · CUSIP 717081103 · Big Pharma · Sector: Healthcare & Biotech

Funds left

Funds are exiting, but the price is holding

Funds that own it
2,851
Institutions that reported holding it to the SEC
Net decrease in holders
116
Last quarter 2,967 → now 2,851
How unusual is that
Bottom 20%
Among the weakest buying in the market
What the filings say, in one paragraph

2,851 funds held PFE at the end of 2026Q2, down 116 from the quarter before. Buying has faded, though the price is holding up. On the business itself, revenue over the last 12 months was $63.7B(YoY -0.2%), the P/E is 39.2x, return on equity is 5.1%. PFE has had 23 buying rushes in its history, and the price moved +1.3% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector, tagged Big Pharma.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=1593 2013Q4: holders=1729 2014Q1: holders=1773 2014Q2: holders=1730 2014Q3: holders=1739 2014Q4: holders=1852 2015Q1: holders=1878 2015Q2: holders=1885 2015Q3: holders=1869 2015Q4: holders=1964 2016Q1: holders=1959 2016Q2: holders=1985 2016Q3: holders=1966 2016Q4: holders=2061 2017Q1: holders=2078 2017Q2: holders=2052 2017Q3: holders=2042 2017Q4: holders=2244 2018Q1: holders=2232 2018Q2: holders=2206 2018Q3: holders=2255 2018Q4: holders=2401 2019Q1: holders=2388 2019Q2: holders=2373 2019Q3: holders=2327 2019Q4: holders=2527 2020Q1: holders=2438 2020Q2: holders=2436 2020Q3: holders=2514 2020Q4: holders=2674 2021Q1: holders=2675 2021Q2: holders=2735 2021Q3: holders=2806 2021Q4: holders=3265 2022Q1: holders=3195 2022Q2: holders=3159 2022Q3: holders=3087 2022Q4: holders=3261 2023Q1: holders=3115 2023Q2: holders=3043 2023Q3: holders=2938 2023Q4: holders=2948 2024Q1: holders=2885 2024Q2: holders=2889 2024Q3: holders=2923 2024Q4: holders=3009 2025Q1: holders=2945 2025Q2: holders=2818 2025Q3: holders=2826 2025Q4: holders=2933 2026Q1: holders=2967 2026Q2: holders=2851 -459 -229.5 +0 +229.5 +459 143324313429 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 23 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 10% -6.4% +15.7%
2025Q4 Top 5% +0.9% -2.4%
2024Q4 Top 5% -3.9% -8.9%
2024Q3 Top 10% +7.0% +7.5%
2022Q4 Top 1% in the market -3.7% -14.1%
2021Q4 Top 1% in the market +3.8% +2.3%
2021Q3 Top 1% in the market +11.4% -3.1%
2021Q2 Top 5% -14.0% +1.5%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
381
Change in large funds
+45
Total value they hold
$92.7B
Funds buying for the first time
161
Funds that sold out entirely
277
Price change that quarter
+7.9%
Funds holding puts (bearish)
52
Funds holding calls (bullish)
60

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

Fundamentals

PE (TTM)
39.2
EPS (TTM)
$0.76
EPS YoY
-59.6%
Revenue (TTM)
$63.7B
Revenue YoY
-0.2%
Net margin
6.8%
ROE
5.1%
Debt ratio
57.5%
FCF (TTM)
$11.0B
Dividend (TTM)
$1.72
Quarterly Revenue & EPS
2021-10-03: EPS 1.42 2021-12-31: EPS 0.59 2022-04-03: EPS 1.37 2022-07-03: EPS 1.73 2022-10-02: EPS 1.51 2022-12-31: EPS 0.86 2023-04-02: EPS 0.97 2023-07-02: EPS 0.41 2023-10-01: EPS -0.42 2023-12-31: EPS -0.59 2024-03-31: EPS 0.55 2024-06-30: EPS 0.01 2024-09-29: EPS 0.78 2024-12-31: EPS 0.07 2025-03-30: EPS 0.52 2025-06-29: EPS 0.51 2025-09-28: EPS 0.62 2025-12-31: EPS -0.29 2026-03-29: EPS 0.47 2026-06-28: EPS -0.04 0B 13.9B 27.7B $B -0.65 0.63 1.90 201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 14 5 36 66 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-2.4B4.2B11B 20162017201820192020202120222023202420252026
Latest quarter $2.2B (2026-03-29)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-28 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.